PUBLISHER: TechSci Research | PRODUCT CODE: 1303138
PUBLISHER: TechSci Research | PRODUCT CODE: 1303138
Flow Cytometry in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component, By Technology, By Indication, By Application, By End User, By company and By Region
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The global flow cytometry in the oncology market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing occurrences of cancer, technological evolution in the field of flow cytometry, and rising consumer awareness for precision medicine and tailored therapy are fueling the growth of the market. Flow cytometry is a biophysical and laser-based analytical technology that is used in the evaluation of cells or micelles that are generally suspended in a fluid with the help of a laser beam. This technique facilitates subclassifying cell types and identifying residual levels of disease using probes to develop an effective treatment plan for the patient. The other factors supporting the market's growth are rapid developments in the field of cancer diagnostics, rise in R&D activities, increasing fund infusions for hematological malignancies, rising adoption of flow cytometry instruments, the exponential rise in the number of cases associated with cancer, rise in world population base, growing adoption of inorganic growth strategies, and increasing emergence of chronic diseases.
Rising Prevalence of Cancer & Hematological Malignancies
Flow cytometry is used to diagnose cancer and detect minimal residue levels. Growing incidences of cancer, such as lung, breast, stomach, skin, throat, and other blood-related cancers, are augmenting the growth of the market. According to WHO, in 2020, cancer is a prominent cause of death, reporting nearly 10 million deaths globally, or nearly one in six deaths. The most common cancers are lung, colon and rectum, breast, and prostate cancers. Also, there is a surge in the number of people suffering from hematological malignancies such as leukemia, lymphoma, and myeloma, which need flow cytometry for the diagnosis and detection of residue. According to the American Cancer Society, in the United States, around every 3 minutes, a person is diagnosed with leukemia, lymphoma, and myeloma.
Growing Consumer Awareness for Tailored Therapy and Precision Medicines
The rising consumer awareness of precision medicine and tailored therapy is bolstering the growth of the market. People are being educated by doctors about the benefits associated with tailored therapy and precision medicine. Precision medicine has invaluable and enormous potential to cure various cancers, thus augmenting the growth of the market. Furthermore, various initiatives by the governments to raise awareness among people are facilitating the growth of the market. For instance, in 2015, The Precision Medicine Initiative (PMI) was launched in the US, an initiative to move away from the "one-size-fits-all" approach to health care delivery and to use tailor treatment and prevention approaches to people's unique individualities, including gene, lifestyle, and biology.
Technological Developments in Cytometry Instruments to Support Market Growth
Rising emphasis of key players on developing advanced flow cytometry products that offer ease in operability, improved workflows, and quick data reading. Owing to the rapid developments in cytometry instruments, the adoption of flow cytometers for therapeutic conducting and monitoring cancer diagnosis is surging, which propels the growth of the market. For instance, in 2018, Merck KGaA launched its new Cell Stream benchtop flow cytometry system, which is a compressed, customizable flow cytometer that uses a camera for detection. With this launch, the company has extended its product line in flow cytometers.
Market Segmentation
The global flow cytometry in the oncology market is segmented into component, technology, indication, application, end user, and company. Based on components, the market is divided into assays & kits, instruments, reagents & consumables, and software. Based on technology, the market is divided into cell-based and bead-based. Based on indication, the market is divided into hematological malignancies and solid tumors. Based on application, the market is divided into translational research and clinical applications. Based on end-user, the market is divided into hospitals & clinics, diagnostic laboratories, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising incidences of cancer and rising advancements in technology in the country.
Market Players
Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioAffinity Technologies, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cytognos, S.L., Danaher Corporation, Miltenyi Biotec BV & Co. KG, and Laboratory Corporation of America Holdings are some of the leading companies operating in the market.
Report Scope
In this report, global flow cytometry in the oncology market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Flow Cytometry in Oncology Market, By Component:
- Assays & Kits
- Instruments
- Reagents & Consumables
- Software
Flow Cytometry in Oncology Market, By Technology:
- Cell-Based
- Bead Based
Flow Cytometry in Oncology Market, By Indication:
- Hematological Malignancies
- Solid Tumors
Flow Cytometry in Oncology Market, By Application:
- Translational Research
- Clinical Applications
Flow Cytometry in Oncology Market, By End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutions
- Others
Flow Cytometry in Oncology Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Turkey
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Flow Cytometry in Oncology Market
Available Customizations
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Flow Cytometry in Oncology Market
5. Voice of Customer
6. Global Flow Cytometry in Oncology Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Component (Assays & Kits, Instruments, Reagents & Consumables, Software)
- 6.2.2. By Technology (Cell Based v/s Bead Based)
- 6.2.3. By Indication (Hematological Malignancies v/s Solid Tumors)
- 6.2.4. By Application (Translational Research v/s Clinical Applications)
- 6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Academic & Research Institutions, Others)
- 6.2.6. By Region
- 6.2.7. By Company (2021)
- 6.3. Market Map
7. North America Flow Cytometry in Oncology Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Component
- 7.2.2. By Technology
- 7.2.3. By Indication
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
- 7.3. North America: Country Analysis
- 7.3.1. United States Flow Cytometry in Oncology Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Component
- 7.3.1.2.2. By Technology
- 7.3.1.2.3. By Indication
- 7.3.1.2.4. By Application
- 7.3.1.2.5. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Canada Flow Cytometry in Oncology Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Component
- 7.3.2.2.2. By Technology
- 7.3.2.2.3. By Indication
- 7.3.2.2.4. By Application
- 7.3.2.2.5. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. Mexico Flow Cytometry in Oncology Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Component
- 7.3.3.2.2. By Technology
- 7.3.3.2.3. By Indication
- 7.3.3.2.4. By Application
- 7.3.3.2.5. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.1. United States Flow Cytometry in Oncology Market Outlook
8. Europe Flow Cytometry in Oncology Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Component
- 8.2.2. By Technology
- 8.2.3. By Indication
- 8.2.4. By Application
- 8.2.5. By End User
- 8.2.6. By Country
- 8.3. Europe: Country Analysis
- 8.3.1. France Flow Cytometry in Oncology Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Component
- 8.3.1.2.2. By Technology
- 8.3.1.2.3. By Indication
- 8.3.1.2.4. By Application
- 8.3.1.2.5. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. Germany Flow Cytometry in Oncology Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Component
- 8.3.2.2.2. By Technology
- 8.3.2.2.3. By Indication
- 8.3.2.2.4. By Application
- 8.3.2.2.5. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. United Kingdom Flow Cytometry in Oncology Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Component
- 8.3.3.2.2. By Technology
- 8.3.3.2.3. By Indication
- 8.3.3.2.4. By Application
- 8.3.3.2.5. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. Italy Flow Cytometry in Oncology Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Component
- 8.3.4.2.2. By Technology
- 8.3.4.2.3. By Indication
- 8.3.4.2.4. By Application
- 8.3.4.2.5. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Spain Flow Cytometry in Oncology Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Component
- 8.3.5.2.2. By Technology
- 8.3.5.2.3. By Indication
- 8.3.5.2.4. By Application
- 8.3.5.2.5. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. France Flow Cytometry in Oncology Market Outlook
9. Asia-Pacific Flow Cytometry in Oncology Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Component
- 9.2.2. By Technology
- 9.2.3. By Indication
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
- 9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Flow Cytometry in Oncology Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Component
- 9.3.1.2.2. By Technology
- 9.3.1.2.3. By Indication
- 9.3.1.2.4. By Application
- 9.3.1.2.5. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. India Flow Cytometry in Oncology Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Component
- 9.3.2.2.2. By Technology
- 9.3.2.2.3. By Indication
- 9.3.2.2.4. By Application
- 9.3.2.2.5. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Japan Flow Cytometry in Oncology Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Component
- 9.3.3.2.2. By Technology
- 9.3.3.2.3. By Indication
- 9.3.3.2.4. By Application
- 9.3.3.2.5. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.4. South Korea Flow Cytometry in Oncology Market Outlook
- 9.3.4.1. Market Size & Forecast
- 9.3.4.1.1. By Value
- 9.3.4.2. Market Share & Forecast
- 9.3.4.2.1. By Component
- 9.3.4.2.2. By Technology
- 9.3.4.2.3. By Indication
- 9.3.4.2.4. By Application
- 9.3.4.2.5. By End User
- 9.3.4.1. Market Size & Forecast
- 9.3.5. Australia Flow Cytometry in Oncology Market Outlook
- 9.3.5.1. Market Size & Forecast
- 9.3.5.1.1. By Value
- 9.3.5.2. Market Share & Forecast
- 9.3.5.2.1. By Component
- 9.3.5.2.2. By Technology
- 9.3.5.2.3. By Indication
- 9.3.5.2.4. By Application
- 9.3.5.2.5. By End User
- 9.3.5.1. Market Size & Forecast
- 9.3.1. China Flow Cytometry in Oncology Market Outlook
10. South America Flow Cytometry in Oncology Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Component
- 10.2.2. By Technology
- 10.2.3. By Indication
- 10.2.4. By Application
- 10.2.5. By End User
- 10.2.6. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Flow Cytometry in Oncology Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Component
- 10.3.1.2.2. By Technology
- 10.3.1.2.3. By Indication
- 10.3.1.2.4. By Application
- 10.3.1.2.5. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Argentina Flow Cytometry in Oncology Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Component
- 10.3.2.2.2. By Technology
- 10.3.2.2.3. By Indication
- 10.3.2.2.4. By Application
- 10.3.2.2.5. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Colombia Flow Cytometry in Oncology Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Component
- 10.3.3.2.2. By Technology
- 10.3.3.2.3. By Indication
- 10.3.3.2.4. By Application
- 10.3.3.2.5. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Flow Cytometry in Oncology Market Outlook
11. Middle East and Africa Flow Cytometry in Oncology Market Outlook
- 11.1. Market Size & Forecast
- 11.1.1. By Value
- 11.2. Market Share & Forecast
- 11.2.1. By Component
- 11.2.2. By Technology
- 11.2.3. By Indication
- 11.2.4. By Application
- 11.2.5. By End User
- 11.2.6. By Country
- 11.3. MEA: Country Analysis
- 11.3.1. South Africa Flow Cytometry in Oncology Market Outlook
- 11.3.1.1. Market Size & Forecast
- 11.3.1.1.1. By Value
- 11.3.1.2. Market Share & Forecast
- 11.3.1.2.1. By Component
- 11.3.1.2.2. By Technology
- 11.3.1.2.3. By Indication
- 11.3.1.2.4. By Application
- 11.3.1.2.5. By End User
- 11.3.1.1. Market Size & Forecast
- 11.3.2. Saudi Arabia Flow Cytometry in Oncology Market Outlook
- 11.3.2.1. Market Size & Forecast
- 11.3.2.1.1. By Value
- 11.3.2.2. Market Share & Forecast
- 11.3.2.2.1. By Component
- 11.3.2.2.2. By Technology
- 11.3.2.2.3. By Indication
- 11.3.2.2.4. By Application
- 11.3.2.2.5. By End User
- 11.3.2.1. Market Size & Forecast
- 11.3.3. UAE Flow Cytometry in Oncology Market Outlook
- 11.3.3.1. Market Size & Forecast
- 11.3.3.1.1. By Value
- 11.3.3.2. Market Share & Forecast
- 11.3.3.2.1. By Component
- 11.3.3.2.2. By Technology
- 11.3.3.2.3. By Indication
- 11.3.3.2.4. By Application
- 11.3.3.2.5. By End User
- 11.3.3.1. Market Size & Forecast
- 11.3.4. Turkey Flow Cytometry in Oncology Market Outlook
- 11.3.4.1. Market Size & Forecast
- 11.3.4.1.1. By Value
- 11.3.4.2. Market Share & Forecast
- 11.3.4.2.1. By Component
- 11.3.4.2.2. By Technology
- 11.3.4.2.3. By Indication
- 11.3.4.2.4. By Application
- 11.3.4.2.5. By End User
- 11.3.4.1. Market Size & Forecast
- 11.3.5. Egypt Flow Cytometry in Oncology Market Outlook
- 11.3.5.1. Market Size & Forecast
- 11.3.5.1.1. By Value
- 11.3.5.2. Market Share & Forecast
- 11.3.5.2.1. By Component
- 11.3.5.2.2. By Technology
- 11.3.5.2.3. By Indication
- 11.3.5.2.4. By Application
- 11.3.5.2.5. By End User
- 11.3.5.1. Market Size & Forecast
- 11.3.1. South Africa Flow Cytometry in Oncology Market Outlook
12. Market Dynamics
- 12.1. Drivers
- 12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
- 14.1. Agilent Technologies, Inc.
- 14.2. Apogee Flow Systems Ltd.
- 14.3. Becton, Dickinson and Company
- 14.4. bioAffinity Technologies, Inc.
- 14.5. Bio-Rad Laboratories, Inc.
- 14.6. Bio-Techne Corporation
- 14.7. Cytognos, S.L.
- 14.8. Danaher Corporation
- 14.9. Miltenyi Biotec B.V. & Co. KG
- 14.10. Laboratory Corporation of America Holdings
15. Strategic Recommendations
